Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Beijing Labsolutions Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Beijing Labsolutions Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Beijing Labsolutions Pharmaceuticals Co., Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Beijing Labsolutions Pharmaceuticals Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Beijing Labsolutions Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Beijing Labsolutions Pharmaceuticals Co., Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Beijing Labsolutions Pharmaceuticals Co., Ltd.'s pipeline products Reasons to buy - Evaluate Beijing Labsolutions Pharmaceuticals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Beijing Labsolutions Pharmaceuticals Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Beijing Labsolutions Pharmaceuticals Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Beijing Labsolutions Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Beijing Labsolutions Pharmaceuticals Co., Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Beijing Labsolutions Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Beijing Labsolutions Pharmaceuticals Co., Ltd. Snapshot 5 Beijing Labsolutions Pharmaceuticals Co., Ltd. Overview 5 Key Information 5 Key Facts 5 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products Glance 10 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Discovery Products/Combination Treatment Modalities 11 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Drug Profiles 12 BL-001 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 BL-003 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 BL-0007 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 BL-006 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 BL-008 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 BL-009 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 BL-011 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 BL-012 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Analysis 20 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Target 20 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 21 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 22 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 25 Disclaimer 25
List of Tables Beijing Labsolutions Pharmaceuticals Co., Ltd., Key Information 5 Beijing Labsolutions Pharmaceuticals Co., Ltd., Key Facts 5 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2014 7 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014 8 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014 9 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Preclinical, 2014 10 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Discovery, 2014 11 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Target, 2014 20 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2014 21 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 22
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.